Your session is about to expire
← Back to Search
RF Health MAC for Orthopedic Disorders (SBIR2 Trial)
SBIR2 Trial Summary
This trial is testing a new device for preventing blood clots after surgery. The device is compared to the standard treatment in 300 patients at two hospitals.
- Orthopedic Disorders
SBIR2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SBIR2 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
May I register for this clinical experiment?
"This clinical trial, which has 300 participants open to enrollment, is seeking candidates aged between 40 and 85 with orthopedic disorders."
Are participants in this clinical trial required to be younger than 25 years of age?
"In agreement with the established requirements, individuals must be 40 years old to join this trial and no older than 85."
Are there still opportunities for participation in this clinical experiment?
"As per clinicaltrials.gov, the advertised medical study is still open for enrolment. It was initially announced on April 1st 2022 and updated most recently on June 7th 2022."
How many participants have volunteered to join in this experiment?
"Affirmative. By consulting clinicaltrials.gov, one can observe that this research project is actively seeking volunteers to be involved in the study; it was first posted on April 1st 2022 and last amended on June 7th of the same year. 300 individuals are required for enrolment at a single trial site."
Share this study with friends
Copy Link
Messenger